Fairtility develops CHLOE, the first transparent AI decision support system for IVF that assesses embryo viability and oocyte quality using extensive data analysis. This technology reduces the number of IVF cycles needed for successful live births, minimizing the emotional and financial burden on prospective parents.
Funding
$16M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
GPFounders
Product
Problem
In vitro fertilization (IVF) success rates are variable, and assessing embryo viability and oocyte quality relies heavily on subjective visual inspection, leading to inconsistencies and potentially unnecessary IVF cycles. This process can result in increased emotional and financial strain for individuals undergoing fertility treatments.
Solution
Fairtility's CHLOE is an AI-driven decision support system designed to enhance IVF outcomes by providing objective assessments of embryo viability and oocyte quality. CHLOE analyzes extensive datasets of patient and embryo data, identifying subtle visual and developmental attributes indicative of implantation potential. By offering transparent insights into the factors influencing embryo quality, CHLOE aims to reduce the number of IVF cycles required to achieve a successful live birth. The system facilitates more informed decision-making by IVF professionals, promoting collaborative discussions with patients and improving the overall efficiency of IVF treatment.
Target Audience
The primary target audience includes IVF professionals and clinics seeking to improve success rates, streamline operations, and provide more transparent, data-driven insights to patients.
Features
- AI-powered assessment of embryo viability based on millions of data points
- Objective oocyte quality assessment to improve selection processes
- Transparent AI algorithms providing visibility into clinical and laboratory parameters
- Streamlined workflows and automated processes to reduce bottlenecks in IVF labs
- Digital tools for simplified data management and enhanced accessibility
- Secure, seamless integration across existing laboratory systems